Literature DB >> 8240281

Interactions between active-site-serine beta-lactamases and mechanism-based inactivators: a kinetic study and an overview.

A Matagne1, M F Ghuysen, J M Frère.   

Abstract

The interactions between three class A beta-lactamases and three beta-lactamase inactivators (clavulanic acid, sulbactam and olivanic acid MM13902) were studied. Interestingly, the interaction between the Streptomyces cacaoi beta-lactamase and clavulanate indicated little irreversible inactivation. With sulbactam, irreversible inactivation was found to occur with the three studied enzymes, but no evidence for transiently inactivated adducts was found. Irreversible inactivation of the S. albus G and S. cacaoi enzymes was particularly slow. With olivanate, irreversible inactivation was also observed with the three enzymes, but with the S. cacaoi enzyme, no hydrolysis could be detected. A tentative summary of the results found in the literature is also presented (including 6 beta-halogenopenicillanates), and the general conclusions underline the diversity of the mechanisms and the wide variations of the rate constants observed when class A beta-lactamases interact with beta-lactamase inactivators, in agreement with the behaviours of the same enzymes towards their good and poor substrates.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8240281      PMCID: PMC1134617          DOI: 10.1042/bj2950705

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  57 in total

1.  Penicillinase active sites: labelling of serine-44 in beta-lactamase I by 6beta-bromopenicillanic acid.

Authors:  V Knott-Hunziker; S G Waley; B S Orlek; P G Sammes
Journal:  FEBS Lett       Date:  1979-03-01       Impact factor: 4.124

2.  A semi-synthetic penicillinase inactivator.

Authors:  S J Cartwright; A F Coulson
Journal:  Nature       Date:  1979-03-22       Impact factor: 49.962

3.  Cross-linking preserves conformational changes induced in penicillinase by its substrates.

Authors:  Y Klemes; N Citri
Journal:  Biochem J       Date:  1980-05-01       Impact factor: 3.857

4.  CP-45,899, a beta-lactamase inhibitor that extends the antibacterial spectrum of beta-lactams: initial bacteriological characterization.

Authors:  A R English; J A Retsema; A E Girard; J E Lynch; W E Barth
Journal:  Antimicrob Agents Chemother       Date:  1978-09       Impact factor: 5.191

5.  Interactions between active-site-serine beta-lactamases and compounds bearing a methoxy side chain on the alpha-face of the beta-lactam ring: kinetic and molecular modelling studies.

Authors:  A Matagne; J Lamotte-Brasseur; G Dive; J R Knox; J M Frère
Journal:  Biochem J       Date:  1993-08-01       Impact factor: 3.857

6.  Inhibition kinetics of three R-factor-mediated beta-lactamases by a new beta-lactam sulfone (CP 45899).

Authors:  R Labia; V Lelievre; J Peduzzi
Journal:  Biochim Biophys Acta       Date:  1980-02-14

7.  Kinetics of suicide substrates.

Authors:  S G Waley
Journal:  Biochem J       Date:  1980-03-01       Impact factor: 3.857

8.  The inhibition of staphylococcal beta-lactamase by clavulanic acid.

Authors:  C Reading; P Hepburn
Journal:  Biochem J       Date:  1979-04-01       Impact factor: 3.857

9.  Chemical studies on the inactivation of Escherichia coli RTEM beta-lactamase by clavulanic acid.

Authors:  R L Charnas; J Fisher; J R Knowles
Journal:  Biochemistry       Date:  1978-05-30       Impact factor: 3.162

10.  Inactivation of Bacillus cereus beta-lactamase I by 6 beta-bromopencillanic acid: mechanism.

Authors:  S A Cohen; R F Pratt
Journal:  Biochemistry       Date:  1980-08-19       Impact factor: 3.162

View more
  6 in total

Review 1.  Pharmacokinetics and Pharmacodynamics of Temocillin.

Authors:  Kevin Alexandre; Bruno Fantin
Journal:  Clin Pharmacokinet       Date:  2018-03       Impact factor: 6.447

2.  Kinetic study of two novel enantiomeric tricyclic beta-lactams which efficiently inactivate class C beta-lactamases.

Authors:  M Vilar; M Galleni; T Solmajer; B Turk; J M Frère; A Matagne
Journal:  Antimicrob Agents Chemother       Date:  2001-08       Impact factor: 5.191

3.  ClbP is a prototype of a peptidase subgroup involved in biosynthesis of nonribosomal peptides.

Authors:  Damien Dubois; Olivier Baron; Antony Cougnoux; Julien Delmas; Nathalie Pradel; Michèle Boury; Bernadette Bouchon; Marie-Agnès Bringer; Jean-Philippe Nougayrède; Eric Oswald; Richard Bonnet
Journal:  J Biol Chem       Date:  2011-07-27       Impact factor: 5.157

4.  Avibactam is a covalent, reversible, non-β-lactam β-lactamase inhibitor.

Authors:  David E Ehmann; Haris Jahić; Philip L Ross; Rong-Fang Gu; Jun Hu; Gunther Kern; Grant K Walkup; Stewart L Fisher
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-02       Impact factor: 11.205

5.  Inhibition of the class C beta-lactamase from Acinetobacter spp.: insights into effective inhibitor design.

Authors:  Sarah M Drawz; Maja Babic; Christopher R Bethel; Magda Taracila; Anne M Distler; Claudia Ori; Emilia Caselli; Fabio Prati; Robert A Bonomo
Journal:  Biochemistry       Date:  2010-01-19       Impact factor: 3.162

6.  Biochemical characterization of CTX-M-15 from Enterobacter cloacae and designing a novel non-β-lactam-β-lactamase inhibitor.

Authors:  Mohammad Faheem; Md Tabish Rehman; Mohd Danishuddin; Asad U Khan
Journal:  PLoS One       Date:  2013-02-21       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.